SCHEMBL29135796

SCHEMBL29135796

CCCCC(C(=O)O)C(=O)CC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.52
MAPK1 P28482 1/20 0.52
GPR84 Q9NQS5 4/20 0.45
FFAR1 O14842 1/20 0.45
SLC1A2 P43004 2/20 0.44
SLC1A1 P43005 2/20 0.44
SLC1A3 P43003 1/20 0.44
MAPT P10636 1/20 0.43
LCK P06239 1/20 0.43
PPARD Q03181 1/20 0.43
ZDHHC20 Q5W0Z9 1/20 0.43
ZDHHC2 Q9UIJ5 1/20 0.43
CHRM1 P11229 1/20 0.42
AKR1A1 P14550 1/20 0.42
CHRM3 P20309 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
ADRA1A P35348 1/20 0.42
HRH1 P35367 1/20 0.42
DRD3 P35462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154159 0.91 GPR84 (0.57) CA2GPR84FFAR1SLC1A2SLC1A1
SCHEMBL30550507 0.91 GPR84 (0.57) CA2GPR84FFAR1SLC1A2SLC1A1
SCHEMBL5048589 0.85 CHRM1 (0.52) CA2MAPK1GPR84FFAR1SLC1A2
SCHEMBL39429 0.85 CA2 (0.61) CA2MAPK1GPR84FFAR1SLC1A2
SCHEMBL4616596 0.84 CA2 (0.50) CA2MAPK1GPR84FFAR1SLC1A2
SCHEMBL10659927 0.84 CA2 (0.40) CA2MAPK1GPR84FFAR1CA1
SCHEMBL17061404 0.83 CHRM1 (0.50) CA2MAPK1GPR84FFAR1SLC1A2
Hydrochloric Acid SCHEMBL628996 0.82 CA2 (0.58) CA2MAPK1GPR84FFAR1SLC1A2
SCHEMBL107263 0.82 CA2 (0.58) CA2MAPK1GPR84FFAR1SLC1A2
SCHEMBL108613 0.82 CA2 (0.58) CA2MAPK1GPR84FFAR1SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117229295-A Nitrogen-containing macrocyclic compound, and preparation method and medical application thereof 中国医药研究开发中心有限公司 2023-12-15 CN disclosed